The study, led by Dr. Brajesh Lal, Director of both the University of Maryland’s Center for Vascular Diagnostics and the NIH Vascular Imaging Core Facility, with participation by the Cleveland Clinic, Weill-Cornell, and Case Western, sought to improve prediction of Major Adverse Neurological Events (MANE; stroke, transient ischemic attack, and amaurosis fugax) by applying AI to traditional carotid imaging using the Elucid Bio vascuCAP software.
Intended to be used on HIV-1 Group M viruses from patients diagnosed with HIV infection, the assays deliver standardized, open and flexible solution suited to clinical settings performing sequencing through Capillary Electrophoresis and Next Generation Sequencing (NGS) systems.
9/14/18: Jeff Kelly, CIO at Nuvodia, a healthcare IT management services provider, states, "Using Exodus to bring our migration expertise in-house has enabled us to improve customer delivery and reduce costs. We are able to put our customers at ease because of the flexibility and robustness of the Laurel Bridge solutions."
7/10/12: Dr. William Mills, President and CEO of Chronic Care Management, Inc. said, "We are pleased to be the first chronic care management patient and practice support organization to publicly release clinical and utilization outcomes for our managed population. Reporting of outcomes drives transparency and illustrates the value of evidence-based attention to ‘in-between visit care."
“We are pleased to expand our solutions across new indications for HOI under Microsoft’s Azure platform, procured for their best-in-class compliance with data security protocol and HIPAA. We believe this is a testament to the power of our real-time smart analytics captured at the point of care in delivering valuable clinical decisions,” said Colt Melby, Chief Executive Officer of ORHub.
Medical Device News Magazine keeps our readers up-to-date on breaking medical device industry news and more!